Consensus guidelines for the management and treatment of neuroendocrine tumors PL Kunz, D Reidy-Lagunes, LB Anthony, EM Bertino, K Brendtro, JA Chan, ... Pancreas 42 (4), 557-577, 2013 | 647 | 2013 |
Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, ... Journal of clinical oncology 37 (4), 286-295, 2019 | 520 | 2019 |
Adoption of total neoadjuvant therapy for locally advanced rectal cancer A Cercek, CSD Roxburgh, P Strombom, JJ Smith, LKF Temple, GM Nash, ... JAMA oncology 4 (6), e180071-e180071, 2018 | 514 | 2018 |
Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial D Schrag, MR Weiser, KA Goodman, M Gonen, E Hollywood, A Cercek, ... Journal of Clinical Oncology 32 (6), 513-518, 2014 | 479 | 2014 |
Twitter social media is an effective tool for breast cancer patient education and support: patient-reported outcomes by survey DJ Attai, MS Cowher, M Al-Hamadani, JM Schoger, AC Staley, ... Journal of medical Internet research 17 (7), e188, 2015 | 411 | 2015 |
Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document GJ Gardner, D Reidy-Lagunes, PA Gehrig Gynecologic oncology 122 (1), 190-198, 2011 | 359 | 2011 |
Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology MH Shah, WS Goldner, AB Benson, E Bergsland, LS Blaszkowsky, ... Journal of the National Comprehensive Cancer Network 19 (7), 839-868, 2021 | 349 | 2021 |
Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas LH Tang, BR Untch, DL Reidy, E O'Reilly, D Dhall, L Jih, O Basturk, ... Clinical Cancer Research 22 (4), 1011-1017, 2016 | 326 | 2016 |
Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors TA Hope, EK Bergsland, MF Bozkurt, M Graham, AP Heaney, K Herrmann, ... Journal of Nuclear Medicine 59 (1), 66-74, 2018 | 299 | 2018 |
Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients R Yaeger, A Cercek, EM O'Reilly, DL Reidy, N Kemeny, T Wolinsky, ... Clinical cancer research 21 (6), 1313-1320, 2015 | 295 | 2015 |
Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases O Basturk, L Tang, RH Hruban, V Adsay, Z Yang, AM Krasinskas, ... The American journal of surgical pathology 38 (4), 437-447, 2014 | 265 | 2014 |
Reliable detection of mismatch repair deficiency in colorectal cancers using mutational load in next-generation sequencing panels ZK Stadler, F Battaglin, S Middha, JF Hechtman, C Tran, A Cercek, ... Journal of Clinical Oncology 34 (18), 2141-2147, 2016 | 242 | 2016 |
Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer A Cercek, KA Goodman, C Hajj, E Weisberger, NH Segal, ... Journal of the National Comprehensive Cancer Network 12 (4), 513-519, 2014 | 240 | 2014 |
Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial J Edeline, Y Touchefeu, B Guiu, O Farge, D Tougeron, I Baumgaertner, ... JAMA oncology 6 (1), 51-59, 2020 | 234 | 2020 |
Identification of germline genetic mutations in patients with pancreatic cancer EE Salo‐Mullen, EM O'Reilly, DP Kelsen, AM Ashraf, MA Lowery, KH Yu, ... Cancer 121 (24), 4382-4388, 2015 | 226 | 2015 |
A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group … PL Kunz, PJ Catalano, H Nimeiri, GA Fisher, TA Longacre, CJ Suarez, ... Journal of Clinical Oncology 36 (15_suppl), 4004-4004, 2018 | 213 | 2018 |
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors MJ Alvarez, PS Subramaniam, LH Tang, A Grunn, M Aburi, G Rieckhof, ... Nature genetics 50 (7), 979-989, 2018 | 192 | 2018 |
Observation versus resection for small asymptomatic pancreatic neuroendocrine tumors: a matched case–control study E Sadot, DL Reidy-Lagunes, LH Tang, RKG Do, M Gonen, MI D’Angelica, ... Annals of surgical oncology 23, 1361-1370, 2016 | 181 | 2016 |
A retrospective review of 126 high-grade neuroendocrine carcinomas of the colon and rectum JD Smith, DL Reidy, KA Goodman, J Shia, GM Nash Annals of Surgical Oncology 21, 2956-2962, 2014 | 172 | 2014 |
PD-1 blockade in advanced adrenocortical carcinoma N Raj, Y Zheng, V Kelly, SS Katz, J Chou, RKG Do, M Capanu, D Zamarin, ... Journal of Clinical Oncology 38 (1), 71-80, 2020 | 167 | 2020 |